Antihypertensive Kombinationstherapie

  • Michael Stimpel

Zusammenfassung

Die Ergebnisse der Hypertension Optimal Treatment (HOT)-Studie (Tabelle 26.2) haben belegt, dass die Häufigkeit kardiovaskulärer Ereignisse proportional zur Senkung des arteriellen Blutdruckes abnimmt. Der Nutzen einer möglichst effektiven Blutdrucksenkung ist für Hypertoniker mit gleichzeitig bestehendem Diabetes mellitus noch größer als für nichtdiabetische Patienten. Während bei Hypertonikern ohne zusätzliche Risikofaktoren der Blutdruck mindestens auf Werte <140/90 mmHg zu senken ist, sollten Hochrisikopatienten mit diabetischer Nephropathie oder Hypertoniker mit begleitender koronarer Herzkrankheit Blutdruckwerte von <130/80 mmHg anstreben.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bakris GL, Griffin KA, Picken MM, Bidani AK (1997) Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury. J Hypertension 15:1181–1185CrossRefGoogle Scholar
  2. Bakris GL, Weir MR, De Quattro V, McMahon FG (1998) Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int 54:1283–1289PubMedCrossRefGoogle Scholar
  3. Brown MJ, Dickerson JEC (1995) Alpha-blockade and calcium antagonism: an effective and well-tolerated combination for the treatment of resistant hypertension. J Hypertension 13:701–707CrossRefGoogle Scholar
  4. Chalmers J (1999) The importance of drug combinations for effective control of hypertension. Clin Exper Hypertension 21:875–884CrossRefGoogle Scholar
  5. Chalmers J, Castaigne A, Morgan T, Chastang C (2000) Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients. Hypertension 18:327–337CrossRefGoogle Scholar
  6. Fenichel RR, Lipicky RJ (1994) Combination products as first-line pharmacotherapy. Arch Intern Med 154:1461–1468CrossRefGoogle Scholar
  7. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Menard J, Julius S, Rahn KH, Wedel H, Westerling S for the HOT Study Group (1998) Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension. Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755–1762PubMedCrossRefGoogle Scholar
  8. Hilleman DE, Ryschon KL, Mohiuddin SM, Wurdeman RL (1999) Fixed-dose combination vs. monotherapy in hypertension: a meta-analysis evaluation. J Hum Hypertension 13:477–483CrossRefGoogle Scholar
  9. Holzgreve H (1996) Antihypertensive Therapie mit fixen Kombinationen. Internist 37:852–856PubMedGoogle Scholar
  10. Kaplan NM (1999) Low dose combinations in the treatment of hypertension: theory and practice. J Hum Hypertension 13:707–710CrossRefGoogle Scholar
  11. Kendall MJ (1995) Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metropolol. Drugs 50:454–464PubMedCrossRefGoogle Scholar
  12. Menard J, Bellet M (1993) Calcium antagonists-ACE inhibitors combination therapy: objectives and methodology of clinical development. J Cardiovasc Pharmacol 21(suppl 2):S49–S54PubMedCrossRefGoogle Scholar
  13. Messerli FH (1999) Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonists. Am J Hypertension 12:86S–90SCrossRefGoogle Scholar
  14. Neutel JM (1999) Low-dose antihypertensive combination therapy: Its rationale and role in cardiovascular risk management. Am J Hypertension 12:73S–79SCrossRefGoogle Scholar
  15. Ruilope LM (1999) Is it wise to combine an ACE inhibitor and an angiotensin receptor antagonist? Nephrol Dial Transplant 14:2855–2856PubMedCrossRefGoogle Scholar
  16. Waeber B, Brunner HR (1995) Main objectives and new aspects of combination treatment of hypertension. J Hypertens 13(suppl 2):S15–S19CrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2001

Authors and Affiliations

  • Michael Stimpel
    • 1
  1. 1.Reha Klinik GmbH DampDampGermany

Personalised recommendations